Literature DB >> 17433490

Heart disease in psoriasis.

Hilal Maradit Kremers1, Marian T McEvoy, Frank J Dann, Sherine E Gabriel.   

Abstract

Psoriasis has been traditionally viewed as an inflammatory skin disorder of unknown origin. Recent advances in the immunopathogenesis and genetics of psoriasis have broadened our understanding of psoriasis. Psoriasis is now considered a systemic inflammatory condition analogous to other inflammatory immune disorders. Patients with other immune disorders, such as systemic lupus erythematosus or rheumatoid arthritis, are known to be at increased risk of heart disease. Similarly, patients with psoriasis may carry an excess risk of heart disease, which would represent an important previously unrecognized cause of morbidity and mortality. This review summarizes the current evidence for an increased cardiovascular risk in patients with psoriasis and outlines deficits in our knowledge in this area.

Entities:  

Mesh:

Year:  2007        PMID: 17433490     DOI: 10.1016/j.jaad.2007.02.007

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  32 in total

1.  The role of nkx2.5 in keratinocyte differentiation.

Authors:  Chul Hwang; Sunhyae Jang; Dae Kyoung Choi; Sujong Kim; Joong Hwa Lee; Young Lee; Chang Deok Kim; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 2.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

3.  Evaluate the effect of cadmium on levels of zinc in scalp hair and blood samples of smoker and nonsmoker psoriatic patients at different stage.

Authors:  Suraya Samejo; Atif G Kazi; Hassan I Afridi; Tasneem G Kazi
Journal:  Environ Sci Pollut Res Int       Date:  2019-09-04       Impact factor: 4.223

4.  Risk and predictors of cardiovascular disease in psoriasis: a population-based study.

Authors:  Hilal Maradit-Kremers; Ross A Dierkhising; Cynthia S Crowson; Murat Icen; Floranne C Ernste; Marian T McEvoy
Journal:  Int J Dermatol       Date:  2013-01       Impact factor: 2.736

5.  Carotid intima-media thickness and serum leptin in psoriasis.

Authors:  B Enany; A K El Zohiery; R Elhilaly; T Badr
Journal:  Herz       Date:  2011-12-01       Impact factor: 1.443

6.  Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI).

Authors:  Zbigniew Siudak; Kalina Wysocka-Dubielecka; Krzysztof Malinowski; Artur Dziewierz; Tomasz Tokarek; Krzysztof Plens; Dariusz Dudek
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

7.  Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients.

Authors:  Raghda Ghonimy Elsheikh; Tarek El-Sayed Amin; Amal Ahmad El-Ashmawy; Samah Ibrahim Abd El-Fttah Abdalla
Journal:  J Saudi Heart Assoc       Date:  2013-12-18

8.  Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?

Authors:  Gamze Erfan; Savas Guzel; Seref Alpsoy; Emine N Rifaioglu; Sule Kaya; Volkan Kucukyalcın; Birol Topcu; Mustafa Kulac
Journal:  Mol Cell Biochem       Date:  2014-11-25       Impact factor: 3.396

Review 9.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

10.  Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.